EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

The effectiveness of using recombinant human bone morphogenetic protein-2 in the reconstruction of alveolar clefts: a meta-analysis

Hongtu Xu, Zhina Liu

Frontiers in Oral Health · 16.06.2026 · 7

DOI: 10.3389/froh.2026.1786495 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Oral Health, online erschienen am 16.06.2026. Verfasst von Hongtu Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shangrao People's Hospital, Shangrao, Jiangxi Province, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The purpose of this study was to examine the available evidence on the impact of using recombinant human bone morphogenetic protein-2 (rhBMP-2) in the reconstruction of alveolar clefts in terms of bone formation rate, bone volume, bone density, and postoperative complications.

Methods

The PubMed, Embase, Web of Science, Scopus, and Cochrane databases were searched until April 2024. The outcomes included bone formation rate, bone volume, bone density, and postoperative complications. Studies comparing autologous iliac bone and rhBMP-2 for osteogenesis in patients with alveolar clefts were included.

Results

Six studies were included. Treatment of an alveolar cleft with autologous iliac bone grafting resulted in higher bone formation, with statistically significant results after a 6-month follow-up period (MD −14.54; 95% CI −21.58 to −7.49; p < 0.0001). Furthermore, at 6 months (MD 186.60; 95% CI 33.26–339.94; p = 0.02) and 12 months (MD 188.70; 95% CI 25.13–352.27; p = 0.02), bone density was lower and the difference was statistically significant. The pooled data indicate that autologous bone graft resulted in statistically significantly higher bone volume (MD −163.09; 95% CI −313.45 to −12.74; p = 0.03). Regarding postoperative complications, no differences were found between the two groups (MD 0.67; 95% CI 0.25–1.78; p = 0.42).

Conclusion

In this study, the application of rhBMP-2 showed no obvious advantage in the reconstruction of alveolar clefts in terms of bone volume and bone formation rate and may result in significant harm. However, further clinical research is required. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/reviewcoversheet

Schlagwörter

Stichwörter der Autor:innen

alveolar bone graftingalveolar ridge crackcleft lipcleft palaterecombinant human bone morphogenetic protein-2t

Autor:innen und Institutionen

  • Shangrao People's Hospital, Shangrao, Jiangxi Province, China.

Zitieren

APA

Xu, H., & Liu, Z. (2026). The effectiveness of using recombinant human bone morphogenetic protein-2 in the reconstruction of alveolar clefts: a meta-analysis. Frontiers in Oral Health, 7. https://doi.org/10.3389/froh.2026.1786495

Vancouver

Xu H, Liu Z. The effectiveness of using recombinant human bone morphogenetic protein-2 in the reconstruction of alveolar clefts: a meta-analysis. Frontiers in Oral Health. 2026;7. doi:10.3389/froh.2026.1786495

BibTeX
@article{Xu2026,
  author = {Xu, Hongtu and Liu, Zhina},
  title = {The effectiveness of using recombinant human bone morphogenetic protein-2 in the reconstruction of alveolar clefts: a meta-analysis},
  journal = {Frontiers in Oral Health},
  year = {2026},
  volume = {7},
  doi = {10.3389/froh.2026.1786495}
}
Kostenlos starten →